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CHAPTER 2: RESULTS AND DISCUSSION (PART I) 
NPE, NV and DEACM-caged iron chelators. 
2.1. NPE-caged iron chelators 
By far the most extensively used group of PRPGs are those belonging to the 2-
nitrobenzyl family, which have been the focus of extensive photochemical 
characterisation and research since they were first reported in the 1960s.[103]  The 
simplest ortho-alkylated nitrophenyl PRPG is the ortho-nitrobenzyl moiety itself (see 
Figure 1.18, I) the photocleavage of which was first reported in 1966 by Schofield et 
al.[114]  The 2-nitrobenzyl entity and its derivatives were first intended for use as 
protecting groups within organic synthesis by virtue of their facile and selective 
photolytic removal.  Additionally, the stability of nitrobenzyl ethers makes them 
chemically unreactive to a wide range of conditions, which has made them especially 
useful for the synthesis of peptides as exemplified by Scheme 2.1.[115]   Light-induced 
cleavage of the ONB group on tyrosine derivative 39 to liberate 40 and nitroso 
compound 26  offers a degree of orthogonality in that selective deprotection of the 






More significantly the benzyl-aryl ether bond is stable under physiological conditions; 
however the nitrosobenzaldehyde photoproduct 26 may be potentially harmful to 
biological systems,[100] which makes the 2-nitrobenzyl group unsuitable for use in a 
caged compound where the objective is to study its effect within a biological system.   
A variation of this caging group is the 2-nitrophenylethyl (2-NPE) moiety (see Figure 
1.18, II)  which has a methyl group on the -carbon atom and has been shown to 
undergo significantly faster photolysis when irradiated at 365 nm.[116]  Such rapid 
photolysis is valuable where caged molecules are designed for a biomedical 









application, and the exposure time of tissue to potentially harmful activating light is 
therefore minimised.  NPE photocleavage results in the generation of a 
nitrosophenylketone (NPK, 35) as shown in Scheme 2.2.  Although it has been 
reported that NPK undergoes reactions with thiol compounds,[117] to date there are no 
published in vitro studies which explicitly describe its toxicity in a particular cell line.  
The NPE moiety has been used as a PRPG in a variety of compounds, although one 
of the earliest examples is the carbamoylcholine derivative 41, in which more 






The photochemical mechanism which describes ortho-nitrobenzyl caging group 
cleavage has been subject to extensive investigation, but is now generally accepted 









It is established that photon capture leads to nitro group excitation, which 
subsequently removes a proton from the -carbon leading to intramolecular electron 
redistribution and formation of the aci-nitro tautomer I.[119]  This nitronic acid species 
Scheme 2.2.One of the first reported NPE-caged compounds and its photolysis to yield NPK 35.                                                               
 
















exists in equilibrium between its two isomeric forms (I and II) through proton transfer; 
however the (E)-isomer II undergoes cyclisation to the benzisoxazoline intermediate 
III which subsequently collapses to the hemiacetal IV.  Decomposition of IV to 
release the free alcohol along with NPK appears to be the rate limiting step to 
complete decaging, and also appears to be pH dependent, occurring much quicker 
under basic conditions. 
Although generation of the aci-nitro tautomer is the only step which requires the input 
of light energy, caging groups with high quantum yields are more attractive for use in 
biomedical applications.  The relatively fast photolysis of NPE has already been 
mentioned; however there is also scope for the design of caging groups which 
undergo photocleavage at longer wavelengths.  It has been demonstrated that simple 
2-nitrobenzyl caged compounds undergo faster release at shorter wavelengths within 
the UV region as one might expect based on their absorption spectra, which is 
demonstrated by tosylate derivative 43 (Scheme 2.4).[119] 











Caging of the aroylhydrazones with the NPE group was achieved by chemical 
blockade of the phenolic oxygen (Scheme 2.5) as exemplified by NPE-PIH 34 below, 
which should undergo photolysis as shown.  The phenol was chosen as the site of 
PRPG attachment because of the relative synthetic ease associated with phenol 







Scheme 2.4.Photorelease of TsOH 44 after irradiation of 43 at various wavelengths of light for 60 min.                                                                                                      
 
















Synthesis of the parent aroylhydrazone chelators, NIH (11) SIH (10) and PIH (8) was 
achieved by condensation of isonicotinic acid hydrazide (INH) with the corresponding 
aldehydes to form the hydrazone as described by Ponka et al. (Scheme 2.6).[72]  The 
aldehyde precursors were 2-hydroxy-1-napthaldehyde, salicylaldehyde and pyridoxal 











For the preparation of NPE-caged aroylhydrazones, O-alkylation of the phenolic 
oxygen was undertaken on the aromatic aldehyde prior to Schiff base formation.  
This strategy was adopted because of the relative structural simplicity of the 
aldehydes compared to their condensed hydrazone counterparts, the latter of which 
contain potentially nucleophilic nitrogen centres that have the potential to undergo 
additional transformations.  NPE-attachment to aromatic aldehydes was achieved 
firstly by creation of a bromine handle on 1-ethyl-2-nitrobenzene 48 under Wöhl-
Ziegler conditions to give the monobrominated benzyl product 49 in 57% yield 
(Scheme 2.7).[120] ABCN was employed as the radical initiator instead of AIBN, which 
was the agent of choice reported by Johnsson and colleagues.  It was found as a 
consequence that the yield of 49 obtained was considerably lower than that reported 
in the literature (90%).  O-alkylation of the 2-hydroxy aryl aldehyde with NPE was 
then achieved under basic conditions with caesium carbonate to give the ‘caged’ 
aldehyde derivatives 50-52 in 56-80% yield. 
Scheme 2.6. Preparation of parent aroylhydrazone ICs 8, 10 and 11.   Reagents and conditions: a. 
























Subsequent condensation of the alkylated aldehydes with INH gave the 
corresponding NPE-caged aroylhydrazones in 32-66% yield (Scheme 2.8).  Although 
these yields are somewhat modest, in all cases the compounds could be readily 
isolated in their pure form, free from unchanged aldehyde by either direct filtration 
from the reaction mixture, or by column chromatography.  In the preparation of NPE-
PIH 34, this step was undertaken in the presence of DOWEX ion exchange resin to 
promote formation of the reactive ‘open’ aldehyde tautomeric form, thus allowing 









Scheme 2.7. Synthesis of O-NPE aldehydes 50-52. Reagents & conditions: a. NBS, ABCN, CCl4, 
reflux, 22 h, 57%; b. 2-hydroxy-1-naphthaldehyde, Cs2CO3, 18-crown-6, DMF, RT, 24 h, 56%; c. 
salicylaldehyde, conditions as with b, 80%; d. pyridoxal HCl, conditions as with b, 68%. 
Scheme 2.8. Condensation reactions of INH and NPE-caged aldehydes.  Reagents and conditions: a. 
INH, 90% aq. EtOH, reflux 22-24 h, 32% (53) or 66% (37); b. INH, DOWEX 50WX8-100, EtOH/H2O 























Synthesis of parent naphthylaldehyde thiosemicarbazone ICs 54a and 54b and their 
corresponding NPE-caged counterparts 55a and 55b was performed in a similar 
fashion to the aroylhydrazones by condensing 2-hydroxy-1-naphthaldehyde with the 
appropriate thiosemicarbazide (Table 2.2, Scheme 2.10, A).  A thiohydrazone 
analogue of PIH, known as H2PTBH (56), and its NPE-caged derivative 57 was also 
similarly prepared from pyridoxal (47) or the NPE-pyridoxal derivative 52 (B).  The 
required precursor for this, thiobenzhydrazide 59, was first prepared by 













 R X Rx* Yield 
54a NMe2 H a 75% 
55a NMe2 NPE a 65% 
54b NH2 H b 87% 
55b NH2 NPE b 39% 
 X Rx* Yield 
56 H d 87% 
57 NPE d 37% 
Scheme 2.10. Preparation of sulfur-containing ICs: NT44mT (54a), NT (54b) and H2PTBH (56), along 
with their NPE-caged derivatives (55a, 55b and 57 respectively).  Also shown is the preparation of 
thiobenzhydrazide 59.  For yields, see Table.  Reagents and conditions:  
 
a. 4,4-dimethyl-3-thiosemicarbazide, EtOH, reflux, 3.5 h;  
b. Thiosemicarbazide, EtOH, reflux, 5 h;  
c. (i) Hydrazine monohydrate, 1 M NaOH, H2O (ii) 5 M HCl, 0 C, 1 h, 98%;  




 Rx = reaction conditions,  
           see Scheme 2.10. 
Scheme 2.9.  
Tautomerism of pyridoxal, showing its 
‘open’ aldehyde (52a) and cyclic furanol 
or hemiacetal form (52). 
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The Schiff base CICs described above are sensitive to acid-catalysed hydrolysis 
when purified by column chromatography over silica gel; however it was found that 
this could be circumvented by adding to the eluent a small amount of pyridine 























2.2. NV-caged iron chelators 
It has been shown that substitution on the aryl ring of nitrobenzyl PRPGs can alter 
their absorption properties, which dictates the wavelength at which they undergo 
photoremoval with optimal efficiency.[122]  The 3,4-dimethoxy-6-nitrobenzyl entity, also 
known as 6-nitroveratryl (NV, see Figure 1.18, II) was first introduced in 1970 by 
Woodward et al.,[123] and has been shown to absorb at longer wavelengths than other 
nitrobenzyl derivatives.  In fact, the NV group is one of few PRPGs reported to work 
at low energy wavelengths as long as 420 nm.[113] Replacement of the position para 
to the nitro group on ring with an electron-withdrawing group however seems to have 







The longer wavelength absorption profile of NV was originally designed for use with 
amino acids such as tryptophan and tyrosine, which are sensitive to shorter 
wavelengths within the UV spectrum.[113]  These properties also make NV attractive 
for use in the preparation of CICs, as its absorption profile,[124] suggests that 
photocleavage should occur more efficiently following exposure to UVA light 
compared to NPE-caged compounds.  It is also important as longer wavelengths of 
light, which are lower in energy are able to penetrate deeper into tissue.   This may 
be particularly relevant for CICs which may have applications as photoprotective 
agents, although a possible problem is the liberation of potentially harmful 
nitrosobenzaldehyde photoproduct 61 (Scheme 2.11).  Nevertheless, photochemical 
comparison of ICs which are caged with NPE and NV should provide some insight 
into how variation of the caging moiety can provide scope for “fine-tuning” their 
photorelease characteristics, and thus help in the rational design of CICs which are 
optimally active within the UVA range. 





















Figure 2.1. Effects of aryl ring substitution 










In similar fashion to the NPE group, the preparation of NV-caged aroylhydrazones 
SIH and PIH was achieved through attach ment of the PRPG to the phenolic oxygen.  
This began with synthesis of 6-nitroveratryl bromide 63 from nitroveratryl alcohol 62 
using PBr3 in anhydrous DCM (Scheme 2.12).  It was anticipated that O-alkylation 
could be accomplished with the conditions used previously with the NPE group; 
however the expected product 64 was not observed when this reaction was 
attempted with salicylaldehyde.  Although TLC showed complete consumption of 
starting material to a single new product, 1H NMR was not consistent with that 







A possible explanation is that the alkylated product, once formed, undergoes a 
subsequent base-induced intramolecular aldol reaction to give a benzofuranyl 
derivative. This is discussed in more detail in section 2.3 (see Figure 2.16).  Indeed, 
deprotonation of the benzylic protons in nitrobenzyl groups is not without precedent, 
as Poggi and coworkers have described the enhanced acidity of the nitrobenzyl 
methylene group within a nickel-complexed scorpionate system.[125]  It is therefore 
feasible that such an active methylene group could then attack the nearby aldehydic 
carbon.[126] 
In view of this result, an alternative alkylation procedure according to Miranda et 
al.[127]  was therefore employed with the milder base, K2CO3,[128] and an increased 
Scheme 2.12. Preparation of nitroveratryl bromide 63 and initial O-alkylation attempts. Reagents and 
conditions: a. PBr3, anhydrous DCM, RT  reflux, 3 h, 77%; b. salicylaldehyde, Cs2CO3, 18-crown-6, 
DMF, overnight, RT.  
Scheme 2.11. Photocleavage of an NV-caged alcohol to release the free alcohol and the 











stoichiometric ratio of bromide 63 relative to the aldehyde (Scheme 2.13).  The 
results of this methodology change were drastic, and the expected benzyl-aryl ethers 
were furnished in 99% (64) or 37% (65) yield.  Subsequent condensation with INH as 
described previously gave the corresponding Schiff base aroylhydrazones in 68% or 
26% yield for the SIH (66) and PIH (67) derivatives respectively.  The low yield 
obtained for the NV-caged PIH was again a consequence of incomplete reaction 
progression, with 42% unchanged aldehyde also recovered following column 


















Scheme 2.13. Synthesis of NV-caged aroylhydrazone ICs 66 and 67.  
Reagents and conditions:  
a. salicylaldehyde, K2CO3, Me2CO, reflux, 5 h, 99%;  
b. pyridoxal hydrochloride, K2CO3, Me2CO, reflux, 5 h, 37%;  
c. INH, 90% aq. EtOH, reflux, 1 h, 68%;  













2.3. Coumarin-4-yl-caged iron chelators 
A third group of PRPGs, structurally unrelated to the ortho-nitrobenzyl caging groups 
which have been the subject of extensive investigation, are the coumarin-4-yl 
moieties.  A considerable number of caged compounds, many of them phosphate-
caged nucleotides[129] have been reported, as well as thiols[130] and alcohols.[131]  
Chemical attachment of coumarinyl PRPGs to molecules is commonly achieved by 
way of an ester or phosphate ester linkage (Figure 2.2), but has also been achieved 
through a carbonate or carbamate spacer depending on the type of functional groups 









The appeal of the coumarinyl system as PRPGs stems from the high absorption 
coefficients and rapid photorelease that is often observed upon irradiation. 
Substituents on the C6 and C7 positions of the ring are established to have a 
significant impact on the photochemical properties of the coumarin chromophores 
and their caged counterparts.  The three most commonly encountered coumarinyl 
PRPGs (see Figure 2.2) are the (7-methoxycoumarin-4-yl)methyl (MCM, I), (7-
diethylaminocoumarin-4-yl)methyl (DEACM, II), and (6-bromo-7-hydroxycoumarin-4-
yl)methyl (BHC, III), and the latter two exhibit especially interesting photochemical 
behaviour.[132]  For instance BHC shows the highest photolytic quantum yields known 
for the coumarin-type groups,[131] while 7-DEACM absorbs at the most red-shifted 
wavelengths, with a max of some DEACM-caged compounds as high as 450 nm.[133]  
This makes DEACM especially appealing for use within CIC preparation, as uncaging 
R = H; R’ = OMe (MCM), I                   
R = H; R’ = NEt2 (DEACM), II                                                   
R = Br, R’ = OH (BHM), III 
Figure 2.2. Examples of coumarinyl caged compounds, depicting various functional groups through 
which attachment of the coumarin moiety can occur. 
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should occur efficiently upon exposure to light within the relatively low-energy UVA 
and visible light region.  It also attractive from a synthetic perspective as unlike BHC 
which contains a phenolic hydroxyl function, there is no need to employ additional 
protecting group measures. 
The range of caging groups which are compatible with the coumarin-4-yl PRPG 
however are limited, for instance aliphatic ethers which result from the caging of non-
phenolic alcohols do not undergo photolysis.  However, light-induced cleavage has 
been accomplished with more electron-rich ether systems such as caged diols[134] 
and with aryl ethers such as those seen with caged purines[132] (see Figure 2.2.) This 
is because photocleavage occurs through solvent-assisted photoheterolysis (Scheme 
2.14) which can only take place when acidic functional groups are caged.[135]  It was 
therefore expected that DEACM should be a promising caging group for CICs 










The preparation of DEACM-caged aroylhydrazones started from 7-diethylamino-4-
methylcoumarin 71, which underwent oxidation at the allyl-activated methyl group 
with selenium dioxide to form the corresponding aldehyde 72 in 35% yield (Scheme 
2.15).  This was subsequently reduced to the hydroxymethyl alcohol 70 using sodium 
borohydride, followed by bromination via the mesylate intermediate which gave the 
coumarin-4-ylmethyl derivative 73 with a reactive bromine handle for subsequent O-
Scheme 2.14. Mechanism of photocleavage of the coumarin-4-ylmethyl caging group, exemplified by 









alkylation.  Unfortunately, the conditions for O-alkylation that were adopted for the NV 
group failed when applied to bromocoumarin 73 and salicylaldehyde; however, 
alkylation of pyridoxal proceeded to give 74 in a satisfactory yield of 46% under these 
conditions, and subsequent condensation with INH as described previously furnished 
the DEACM-caged PIH derivative 75.  Changing the solvent to DMF or adjusting the 
stoichiometry ratios of the coumarinyl bromide and/or base gave no improvement 


















One possible explanation for the difficulty in alkylating salicylaldehyde under these 
conditions is the occurrence of a base-catalysed intramolecular aldol reaction which 
results in the formation of a benzofuranyl product (Scheme 2.16), which has been 
reported by Ghate et al. who had employed similar conditions with both aldehyde and 
Scheme 2.15. Synthetic route of DEACM-caged PIH 75 and failed 
O-alkylation of salicylaldehyde with coumarinyl bromide 73. 
Reagents and conditions:  
a. SeO2, p-xylene, reflux, overnight, 35%;  
b. NaNH4, i PrOH, RT, 1 h, 53%;  
c. (i) MeSO2Cl, Et3N, DCM, 0 C, 15 min;  
c. (ii) LiBr, THF, RT, 3 h, 89%;  
d. salicylaldehyde, K2CO3, Me2CO or DMF, reflux, 2-5 h; 
e. pyridoxal HCl, K2CO3, Me2CO, reflux, 5 h, 46%. 

















coumarin substrates.[126]  Indeed, this would explain why pyridoxal was able to 
undergo alkylation with 73 to give the expected ether product, as it exists entirely in 
its furanol form, thus meaning the aldehyde is “protected” from any attack by the 








As an alternative approach, we attempted to attach the DEACM group to the phenolic 
function of salicylaldehyde by activating the coumarinyl alcohol 70 under Mitsunobu 
conditions[132] (Scheme 2.17).  However this proved unfruitful, and the expected aryl 














Scheme 2.17. Attempted attachment of the DEACM group to phenolic oxygen under Mitsunobu 
conditions.  Reagents and conditions: salicylaldehyde, DEAD, PPh3, THF, RT, overnight. 
Scheme 2.16. Mechanism of the intramolecular aldol reaction and the resulting formation of a 







With the formation of a coumarin-4-ylmethyl-aryl ether proving difficult, we also 
considered the possibility of caging the phenolic aldehydes with the DEACM group 
through a carbonate ester, a route which is frequently employed in the synthesis of 
coumarinyl-caged compounds.  This was attempted with salicylaldehyde and 
coumarinyl alcohol 70 as shown in Scheme 2.18, via formation of the para-
nitrophenyl carbamate-ester intermediate as described by Hagen et al.[136]  Although 
a new product was detected by TLC analysis, the expected product (77) was not 







Based on the apparent base sensitivity of the coumarinyl derivative of 
salicylaldehyde (76), we finally attempted to design a set of alkylation conditions 
under which any excess of base could be avoided, thus minimising the risk of 
unwanted intramolecular aldol product formation.  Rίos et al. have reported the 
alkylation of phenolic aldehydes with potassium tert-butoxide as a base, a method 
which was therefore implemented but with some slight modifications.[137]  In 
particular, a sub-stoichiometric amount of base was used in this reaction (0.9 equiv.) 
relative to the phenolic substrate.  A solution of potassium tert-butoxide in THF, 
obtained commercially, was employed which allowed for a much tighter level of 
control in the amount of base used.  It was then anticipated that ‘pre-formation’ of the 
salicylaldehyde phenoxide anion, followed by subsequent slow addition of the 
deprotonated species to a solution of excess bromomethylcoumarin 73 should 
prevent any base-catalysed intramolecular-aldol products.  This method proved 
successful, and the expected ether 76 was produced in 48% yield, which was 
subsequently condensed as described previously to give the complete DEACM-
caged IC 78 in 54% yield (Scheme 2.19). 
Scheme 2.18.  Attempted O-alkylation of salicylaldehyde with DEACM by formation of a carbonate 
ester 77. Reagents and conditions: (i) para-nitrophenyl chloroformate, DMAP, DMF, RT, overnight (ii) 






























Scheme 2.19. Successful base-catalysed formation of benzyl-aryl ether 76 from bromomethyl 
coumarin 73 and subsequent aroylhydrazone 78 formation.  Reagents and conditions: a. 
Salicylaldehyde, t BuOK, THF, RT, 2 min, then slow addition of mixture to 73 in THF, 50 C, 3 h, 48%; 







2.4. Synthesis of NPK 
In addition to the synthesis of NPE-CICs, it was decided that it would be useful to 
obtain NPK (35) which is produced from the photolysis of NPE-CICs.  This is for two 
reasons: firstly, it would allow us to establish a retention time for this compound by 
HPLC analysis, thus establishing an invaluable reference marker for the analysis of 
NPE-CIC uncaging following irradiation.  Secondly, it would allow us to directly 
evaluate its in vitro biological activity in a relevant biological system, such as 
keratinocyte skin cells, which to our knowledge has never been studied.  The latter 
point is particularly important, as any cell killing observed upon decaging can then be 
reliably attributed to release of the active IC component. 
To attain NPK, one possible strategy is to synthesise it photochemically; whereby an 
NPE-caged compound is irradiated and the nitrosoketone by-product is isolated by 
chromatography.  A problem with this approach however is that a relatively large 
amount of caged compound would be required to obtain an adequate amount of 
nitrosoketone.  Also if uncaging does not occur cleanly, then purification by column 
chromatography may prove difficult.  We therefore decided to prepare NPK non-
photochemically using the route depicted in Scheme 2.20.  This was accomplished 
easily, from the commercially available nitrophenyl alcohol 79, which when converted 
to the mesylate underwent subsequent base-catalysed elimination to nitrostyrene 
80.[138]  Treatment with strong acid protonates the vinyl bond and results in formation 
of a carbocation formation which is subsequently attacked by the nitro oxygen.[139]  
The intramolecular rearrangement that follows affords nitroso ketone 35 in 61% yield. 
 
 





Scheme 2.20.  Non-photochemical synthesis of NPK 35.  Reagents and conditions: a. MeSO2Cl, DBU, 











2.5. Decaging experiments 
2.5.1. General information 
Removal of the NPE, NV and DEACM caging groups from CICs by irradiation with 
UV light to release the active aroylhydrazone CIC and NPK fragment (“decaging”) 
was performed on all CICs described.  
Decaging experiments were originally performed with CIC solutions in MeCN; 
however with some compounds it was found that solubility of the CIC and/or the 
resulting photoproducts was too poor in this solvent.  DMSO was therefore used as 
the solvent of choice, with CICs, reference ICs and all photoproducts possessing full 
solubility in this solvent at the concentrations used, namely 0.05% w/v. 
Irradiation was conducted with a broad-spectrum Sellas 4kW UVA lamp which emits 
primarily within the UVA range (350-400 nm); however there is also low-level 
emission within the near-visible range above 400 nm.  The emission spectrum of the 











CICs were exposed to a UV dose of 250 kJ/m2.  This is roughly equivalent to an 
exposure time of 70 minutes midday sunlight, during the summer at northern latitude 
Figure 2.3. Emission spectrum of the Sellas UVA lamp used for decaging experiments.  
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of 30-35 degrees.[140]  This dose of UVA was selected as it is considered to be 
physiologically relevant, and therefore reflects a level of exposure which is likely to 
elicit damage to skin tissue without solar protection.  It is also a level of exposure 
which people are likely to encounter throughout various parts of the world, and 
should provide an adequate level of energy for the photolysis of CICs to take place. 
Approximately 1 hour post-irradiation, samples were characterised by HPLC analysis, 
detecting at a wavelength of 280 nm (unless otherwise stated) and compared to 




















2.5.2. UV absorption spectra 
The UV absorbance profiles of all compounds described within this chapter were 
measured and recorded, including the max and molar absorption coefficient .  For 
experimental details and methodology, see section 6.3.  For UV absorbance data of 
individual compounds, see under the relevant compound in section 6.2. 
Figure 2.4 shows the UV absorbance spectrum for three caged-PIH derivatives, 
namely the NPE, NV and DEACM-caged compounds 34, 67 and 75 respectively.  As 
expected, the DEACM-caged compound 75 shows considerably red-shifted 
absorption compared to its NPE and NV counterparts, with absorption maxima at 381 
nm.  In contrast, relative to the NPE-caged compound the NV-PIH derivative also 
shows a slight bathochromic shift (296 and 300 nm respectively).  This pattern was 















Figure 2.4. UV absorption profiles of the three caged PIH derivatives: NPE-PIH 34, NV-PIH 67 and 
DEACM-PIH 75 at a concentration of 40 M. 
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2.5.3. Stability of parental ICs to UVA light 
The stability of the parental (“naked”) ICs 8, 10-11, 54a-b and 56 to UVA light were 
evaluated by dissolving in DMSO at a concentration of 0.05% w/v and irradiating at a 
dose of 250 kJ/m2.   
The ICs showed no evidence of UVA-induced degradation, except for the two 
thiosemicarbazone ICs 54a-b, where the emergence of a weak signal suggested  








2.5.4. Stability of NPE-caged iron chelators to visible light 
Ideally, CICs should be resistant to photolysis by radiation within the visible light 
region of the electromagnetic spectrum (380-740 nm), as premature uncaging in 
ambient light would circumvent the current objective of producing context-specific 
iron chelation.  
In order to evaluate their stability to ambient light, all NPE, NV and DEACM-caged 
ICs described in this chapter were dissolved in DMSO at a concentration of 0.05% 
w/v and allowed to stand overnight (15-16 h) in the fume hood under normal light 
emitted by a fluorescent lamp at RT.  We anticipated that this should mimic a typical 
daily level of indoor, non-solar visible light that human skin is exposed to.  
Analysis of the samples by HPLC showed no photolysis or uncaging under these 
conditions for any of the compounds, thus indicating the stability of the NPE, NV and 




















Figure 2.5. HPLC chromatograms of thiosemicarbazone ICs 54a (A) and 54b (B) following exposure 








2.5.5. Uncaging of NPE-caged aroylhydrazones 
Figure 2.6 shows the uncaging profile for NPE-SIH, the HPLC chromatogram for 
which is shown under normal conditions (A) and 1 hour after irradiation with UVA (B).  
It can be seen that at this dose of UVA radiation, the caged compound appears to 
undergo complete photolysis, as the chromatogram signal for 37 is no longer 
observed in the irradiated sample. Furthermore, two new signals are generated which 
appear to correlate with the chromatogram profiles of SIH 10 (C) and NPK 35 (D), 
which is further confirmed by co-injection of the irradiated sample with either SIH (E) 















NPE-PIH 34 exhibits the same decaging behaviour as SIH, with full release of the 
iron chelator and the NPK fragment (Figure 2.7), although some very minor side 
photoproducts appear to also be present.  
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Figure 2.6. HPLC chromatograms of NPE-SIH 37 and its photoproducts, depicting the caged 
compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  Also shown for reference is the 
‘naked’ IC molecule SIH (C) and NPK (D) as well as co-injection of the irradiated sample with either 
















Similarly, NPE-NIH 53 exhibited decaging which is consistent with our expectations, 
in that total photolysis occurs at a UVA dose of 250 kJ/m2 and that the ‘naked’ NIH 
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WVL:280 nm Figure 2.7.  
HPLC chromatograms of NPE-
PIH 34 and its photoproducts, 
depicting the caged compound 
(A) and the UVA irradiated 
(250 kJ/m2) compound (B).  
‘Naked’ PIH 8 (C), NPK (D) 
and co-injection of the 
irradiated sample with NPK 35 
(E) are also shown for 
reference 
Figure 2.8.  
HPLC chromatograms of NPE-
NIH 53 & its photoproducts, 
depicting the caged compound 
(A) and the UVA irradiated 
(250 kJ/m2) compound (B).  
‘Naked’ NIH 11 (C), NPK 35 
(D) and co-injection of the 
irradiated sample with NIH (E) 
are also shown for reference 










The NPE-caged thiosemicarbazone compound 55a, (Figure 2.9) appears to undergo 
relatively clean photolysis to yield the naked IC and NPK (B), as evident from 
reference chromatograms of the free chelator molecule (C) and NPK (D).  As before, 
the identity of the signal with a retention time (Rt) of 9.1 min is confirmed as the free 
IC by co-injection of 54a with the irradiated sample (E).  Interestingly, photolysis does 
not appear to fully occur at a dose of 250 kJ/m2 however, as a signal which 












Despite only partial photolysis being observed, this compound has two absorption 
maxima at 238 and 360 nm, with a molar extinction coefficient,  of 39786 and 15017 
L mol-1 cm-1 respectively.  As this would indicate a reasonable level of absorption 
within the UVA range, and is comparable with the absorption profiles of the other 
NPE-CICs described in this chapter, it is surprising that this compound does not 
undergo complete decaging. 
 
 






















































A B C 
D E 
Figure 2.9.  
HPLC chromatograms of 55a 
and its photoproducts, depicting 
the caged compound (A) and 
the UVA irradiated (250 kJ/m2) 
compound (B). The “Naked” IC 
54a (C), NPK 35 (D) and co-
injection of the irradiated 
sample with 54a (E) are also 







The other NPE-caged thiosemicarbazone compound 55b (Figure 2.10, A) exhibits 
more favourable photolytic behaviour following irradiation (B) as photocleavage 
occurs fully and cleanly, with only two photoproducts released which are identified as 
the naked IC (C) and NPK (not shown) which can be attributed to the signal at 7.8 









With the NPE-caged thiohydrazone analogue of PIH, H2PTBH (57), it appears that 
the extent of photolysis is relatively high (Figure 2.11), owing to a considerable 
reduction in the signal intensity of the intact caged compound (A  B).  It is likely 
that the new signal with an Rt value of 7.78 min is NPK (B); however the identity of 
the new signal with an Rt value of 6.43 min is uncertain as this differs from the 
reference value of the ‘naked’ chelator molecule by 0.25 min (C), a significant 
difference.  On the other hand, co-injection of the irradiated sample with the “naked” 
IC (56) shows the appearance of no additional signals, suggesting that the signal 
with an Rt value of 6.4-6.5 min is derived from the free chelator.  Significantly, the 
appearance of a signal with an Rt value of 5.66 min (B) cannot be attributed to any of 
the expected photoproducts, suggesting that additional photoproduct generation 






















Figure 2.10. HPLC chromatograms of the NPE-NT compound 55b and its related photoproducts, 
depicting the caged compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  The “naked” IC 
molecule 54b is shown for reference (C). 
















































































Figure 2.11.  
HPLC chromatograms of 57, and its related photoproducts 
depicting the caged compound (A) and the UVA irradiated (250 
kJ/m2) compound (B).  The “naked” IC molecule 56 is shown for 
reference (C) and co-injection of the irradiated sample with the 








2.5.6. NV-caged aroylhydrazones 
The decaging profiles of nitroveratryl (NV) caged aroylhydrazones are shown below, 
namely NV-SIH (66, Figure 2.12) and NV-PIH (67, Figure 2.13).  NV-SIH 66 is shown 
in the dark and after irradiation (B), and it can be seen that photolysis occurs 
completely and in a relatively clean fashion, with the new major signal appearing to 
correspond with SIH as expected (C).  The other minor signal (B) is likely to 









Similarly, NV-PIH 67 (Figure 2.13) decages to liberate PIH (A  B) which is evident 
from the reference chromatogram of PIH (C); however as with irradiation of NV-SIH 
the formation of nitrosobenzaldehyde is not obvious from these chromatograms, 







2.5.3. DEACM-caged compounds 

























Figure 2.12. HPLC chromatograms of NV-caged SIH 66 and its photoproducts, depicting the caged 
compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  The ‘naked’ SIH molecule 10 is 
shown for reference (C). 


























Figure 2.13. HPLC chromatograms of NV-caged PIH 67 and its related photoproducts, depicting the 
caged compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  The ‘naked’ PIH molecule 8 







2.5.7. DEACM-caged aroylhydrazones 
Irradiation of the 7-diethylaminocoumarin-4-ylmethyl (DEACM) caged compounds are 
shown below. Interestingly, for DEACM-SIH 78 the product appears to undergo only 
partial photocleavage at 250 kJ/m2 (Figure 2.14) as the signal relating to the caged 
compound (A) remains even after irradiation, although a signal relating to SIH (C) 
appears to be present, suggesting that a relatively low level of photorelease has 








DEACM-caged PIH 75, the decaging profile of which is shown in Figure 2.15  exhibits  
similar behaviour to its SIH counterpart, as it is evident that a significant amount of 
intact caged compound (A) remains after irradiation (B), although a degree of PIH 






























Figure 2.15. HPLC chromatograms of DEACM-caged PIH 75 and its related photoproducts, depicting 
the caged compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  The ‘naked’ PIH 
molecule 8 is shown for reference (C). 







A B C 
Figure 2.14. HPLC chromatograms of DEACM-caged SIH 78 and its related photoproducts, depicting 
the caged compound (A) and the UVA irradiated (250 kJ/m2) compound (B).  The ‘naked’ SIH 
molecule 10 is shown for reference (C). 




































As the UV absorption profile of DEACM-CICs 75 and 78 are considerably red-shifted 
compared to the NPE and NV-CICs, irradiation with a light source of longer 
wavelength may result in more extensive photolysis.  In fact, the wavelength-
selective photolysis of a mixture of NPE and DEACM compounds has been 






















2.6. Biological experiments: background 
For experimental and methodology details, see experimental section 6.4. 
 
2.6.1. MTT assay 
Relative cytotoxicity was measured by MTT assay, which uses the tetrazolium dye 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, 81) which is 







The amount of formazan produced can be measured colorimetrically, which gives a 
measure of metabolic activity within the cell and is therefore directly proportional to 
the viable cell number.  Thus, when MTT assays are performed with cells that are 
incubated with compounds of interest, it can be used to deduce the relative 
cytotoxicity of these compounds. 
 
2.6.2. BrdU assay 
The BrdU assay uses the synthetic nucleotide analogue 5-
bromo-2’-deoxyuridine, (83, Figure 2.16) which gives the assay 
its name.  During the S phase of the cell cycle, this analogue is 
incorporated into the newly replicated DNA of dividing cells 
instead of thymidine.  BrdU-specific antibodies bind to this 
nucleotide analogue, and a second antibody conjugated to 
Scheme 2.21.  Enzymatic reduction of the tetrazole MTT 81 to its purple formazan product 82 
 
 
Figure 2.16.   
 










fluorescein isothiocyanate (FITC) then successively binds to the BrdU-specific 
antibody.  Thus, cells which were actively replicating their DNA can be detected by 
fluorescence of the FITC marker.   
 
2.6.3. Clonogenic (colony forming) assay 
The clonogenic assay (colony forming assay, CFA) is the most reliable way to 
evaluate viable cell number, and is based on a single cell’s ability to grow into a 



















2.7. Biological experiments: results and discussion. 
2.7.1. Toxicity of parental iron chelators in HaCaT cells  
The relative toxicity of PIH and SIH in the HaCaT cell line are already known from 
previous studies conducted in the Pourzand laboratory, with IC50 values of 100 M 
and 20 M respectively (data not shown).[145]  The biological activity of the remaining 
ICs described within this chapter have not been evaluated however in this cell line 
The effect of the aroylhydrazone NIH 11, the thiosemicarbazones 54a-b, and the 
PIH-thiohydrazone analogue H2PTBH 56 on HaCaT cell growth at various 
concentrations and incubation times is shown below (Figures 2.17-2.20). As one 
might anticipate, the inherent toxicity or growth-inhibitory effect of these compounds 
appears to be time dependent, as growth is significantly reduced in cells incubated 
for 72 h compared to those treated for just 24 h, and this is seen in at least two 














Figure 2.17. MTT assay: toxicity of  11 in HaCaT cells after incubation for 24, 48 or 72 h (n = 3-5)   
  p < 0.05, significantly different from corresponding untreated controls.  
# p < 0.05, significantly different from treatment with 11 at 2.5 M at same timepoint. 
† p < 0.05, significantly different from treatment with 11 at 5 M at same timepoint 
‡ p < 0.05 significantly different from treatment with 11 at 10 M at same timepoint 
§ p < 0.05 significantly different after treatment with 11 for 24 h at same concentration 




































Figure 2.18. MTT assay: toxicity of 54a in HaCaT cells after treatment for 24, 48 or 72 h (n = 3-5)                    
  p < 0.05, significantly different from corresponding untreated controls.  
# p < 0.05, significantly different from treatment with 54a at 2.5 M at same timepoint. 









Figure 2.20. MTT assay: toxicity of 56 in HaCaT cells after treatment for 24, 48 or 72 h (n = 4)                    
  p < 0.05, significantly different from corresponding untreated controls 
† p < 0.05, significantly different from treatment with 56 at 25 M at same timepoint 
‡ p < 0.05 significantly different from treatment with 56 at 50 M at same timepoint 





Figure 2.19. MTT assay: toxicity of 54b in HaCaT cells after treatment for 24, 48 or 72 h (n = 3-5)                    
  p < 0.05, significantly different from corresponding untreated controls.  





















This data are summarised in Figure 2.21. It can be deduced that, after a 72 h 
incubation time compounds 11, 54a, and 54b have an IC50 value of < 5 M; whereas 
the IC50 values for 8 and 56 are considerably higher, with an IC50 of 100 M for PIH 
and > 25 M for H2PTBH (Figure 2.20).  These findings are consistent with our 
expectations, as the more lipophilic compounds such as NIH and NT44mT possess 
the most cytotoxic effect, whereas the more hydrophilic compound H2PTBH has 









These results were closely reproduced by the colony forming assay (Figure 2.22).  
For example, cells treated with the naphthylaldehyde-derived ICs, namely NIH (11) 
NT44mT (54a) and NT (54b) show a greater reduction in growth rate and colony 
formation compared to SIH, because of their greater lipophilicity.  In agreement with 
the MTT data, NIH appears elicits the highest degree of cytotoxicity compared to its 






Figure 2.21. Summary of growth inhibitory effects of the parental ICs measured by MTT assay: NIH 











Figure 2.22.   
Adjusted results of the colony 
forming assay undertaken with 





2.7.2. Comparative toxicity of CICs and UVA-irradiated CICs by MTT assay 
The growth inhibitory effect of NPE, NV or DEACM-caged CICs in HaCaT cells was 
evaluated by MTT assay in the same way as described above with the parental ICs. 
HaCaT cells were treated with the CIC, the corresponding ‘naked’ IC and the UVA-
irradiated CIC which had been irradiated at a dose of 250 kJ/m2.  The concentration 
of compound added was determined by the estimated IC50 value deduced from the 
above experiments.  As before, cellular enzymatic activity was measured at 24 h, 48 
h or 72 h post-treatment with compounds.   
A comparative study with the aroylhydrazones SIH and PIH and their corresponding 
NPE-caged derivatives 34 and 37 was conducted prior to this project.  The results 
are shown in Figure 2.23, where HaCaT cells were treated with SIH or PIH and their 
corresponding NPE-caged compounds, along with the respective UVA-irradiated 
NPE-CICs.  All compounds were added at a final concentration of 100 M; however 












It is apparent that PIH and its derivatives show less toxicity than SIH and its NPE-
caged analogue at this concentration, whether irradiated or not.  At this 
Figure 2.23.  MTT assay for the ‘naked’ (IC), NPE-caged (CIC) and UVA-irradiated NPE-caged (CIC + 
UVA) derivatives of PIH (8 or 34) (n = 3-4) and SIH (10 or 37) (n = 2) at 100 M in HaCaT cells 72 h 
post treatment 
* p < 0.05, significantly different from corresponding untreated controls.  
# p < 0.05, significantly different from naked chelator at same concentration and same timepoint. 








concentration, SIH is considerably more toxic than PIH in this cell line, which is 
consistent with the notion that increased lipophilicity is associated with more potent 
cytotoxicity.  With both SIH and PIH, the NPE-caged derivative is considerably less 
toxic than the uncaged parent chelator as anticipated, and upon irradiation this 
antiproliferative effect appears to be restored to a level which is similar to that of the 
parental IC 
Activity of the CIC compound 53 (NPE-NIH), including the intact (CIC) and UVA-
irradiated compound (CIC+UV), along with its ‘naked’ NIH counterpart in HaCaT cells 




















Figure 2.24.  MTT assay for the parental (IC), NPE-caged (CIC) and UVA-irradiated NPE-caged 
(CIC + UVA) derivatives of 53 at 5 M (A) and 10 M (B) in HaCaT cells (n = 3). 
*  p < 0.05, significantly different from control cells at same timepoint.  
# p < 0.05, significantly different from naked chelator at same concentration and same timepoint. 








As anticipated, the caged compound 53, possesses the lowest level of toxicity, and 
after 72 h at 10 M over 75% of cells remain viable.  The ‘naked’ NIH molecule 
however possesses marked toxicity compared to its caged counterpart, with 
significantly higher cytotoxicity apparently observed with longer incubation times and 
at higher concentrations as one would expect.  When 53 is irradiated with UVA at a 
dose of 250 kJ/m2, an increase in cytotoxicity is observed relative to the ‘dark’ caged 
compound and control cells; however the reduction in cell viability never reaches the 
same level as the naked NIH chelator, which in theory it should providing  that 
complete photolysis takes place.  Thus, these results strongly suggest that NPE-NIH 
remains inactive unless activated by UVA irradiation, where a significant decrease in 


















Activity of the CIC compound 55a (NPE-NT44mT), including the intact (CIC) or UVA-
irradiated NPE-caged compound (CIC + UV), along with its ‘naked’ counterpart 54a is 
shown below in Figure 2.25.  As anticipated, the parental IC exhibits higher toxicity 
than the NPE-caged compound, however the irradiated compound shows a similar 
level of toxicity to the intact caged compound.  From this, one could deduce that the 
CIC is simply not decaging; however the decaging profile for this compound (see 
Figure 2.26) suggests that the ‘naked’ chelator is indeed released following UVA 
irradiation as expected.  Therefore, assuming that photolysis is proceeding as 
expected, another explanation is that the NPK fragment may be attenuating the 

















Figure 2.25.  MTT assay for the parental (IC, 54a), NPE-caged (CIC, 55a) and UVA-irradiated NPE-
caged (CIC + UVA) derivatives of NT44mT at 10 M (A) and 20 M (B) in HaCaT cells (n = 3) 
# p < 0.05, significantly different from naked chelator at same concentration and same timepoint. 








Interestingly, the same pattern is observed with NPE-NT (55b) and its derivatives 
(Figure 2.26), where, again in most cases the UVA-irradiated CIC exhibits a similar 
level of toxicity to the unirradiated CIC.  It is worth noting that this observation is more 
pronounced in cells treated with the higher concentration (B).  The decaging profile of 
NPE-NT shows that photolysis at 250 kJ/m2 is only partial, and so it is reasonable to 
expect that the level of toxicity observed with the UVA-irradiated compound would 
not be as marked as that seen with the ‘naked’ IC molecule, as is apparent at the 
lower concentration of compound (A).  This however fails to explain the observations 

















Figure 2.26.  MTT assay for the parental (IC, 54b), NPE-caged (CIC, 55b) and UVA-irradiated NPE-
caged (CIC + UVA) derivatives of NT at 5 M (A) and 10 M (B) in HaCaT cells (n = 4) 
*  p < 0.05, significantly different from control cells at same timepoint.  
# p < 0.05, significantly different from naked chelator at same concentration and same timepoint. 








Activity of the thiohydrazone-PIH analogue H2PTBH, including the intact (CIC, 57) or 
UVA-irradiated NPE-caged compound (CIC + UV), along with its ‘naked’ counterpart 
56 is shown below in Figure 2.27.  As anticipated the caged compound 57 exhibits a 
lower toxicity than its parental counterpart 56, although this finding is more marked at 
higher concentrations (B).  As observed with the thiosemicarbazone derivatives 
NT44mT and NT, the UVA-irradiated caged compound displays a similar degree of 
cytotoxicity to the intact or unirradiated caged-compound.  The decaging profile for 
NPE-H2PTBH (46) suggests that the expected photoproduct is released, but is 
accompanied by a considerable level of unexpected photoproduct generation (see 
Figure 2.11).  These additional photoproducts, the identities of which are currently 


















Figure 2.27.  MTT assay for the ‘naked’ (IC, 56), NPE-caged (CIC, 57) and UVA-irradiated NPE-
caged (CIC + UVA) derivatives of H2PTBH at 50 M (A) and 100 M (B) in HaCaT cells (n = 3). 
*  p < 0.05, significantly different from control cells at same timepoint.  







Activity of the NV-SIH compound 66, including the intact (CIC) or UVA-irradiated 
NPE-caged compound (CIC + UV), along with its ‘naked’ counterpart is shown below 
in Figure 2.28.  Unexpectedly the NV-caged compound 67 displays higher 
cytotoxicity than its UVA-irradiated or parental counterpart, which suggest that the 



















Figure 2.28.  MTT assay for the ‘naked’ (IC, 10), NV-caged (CIC, 66) and UVA-irradiated NV-caged 
(CIC + UVA) derivatives of SIH at 20 M (A) and  40 M (B) in HaCaT cells (n = 3). 
*  p < 0.05, significantly different from control cells at same timepoint.  
# p < 0.05, significantly different from naked chelator at same concentration and same timepoint. 
† p < 0.05, significantly different from caged chelator at same concentration and same timepoint 









Activity of the NV-PIH compound 67, including the intact (CIC) or UVA-irradiated 
NPE-caged compound (CIC + UV), along with its ‘naked’ counterpart is shown below 
in Figure 2.29.  There were no significant differences between the toxicity of the 
naked chelator, the NV-CIC, or the UVA-irradiated NV-CIC.  Toxicity of the caged 
compound is neglible, whether UVA irradiated or not, even at the high treatment 











Activity of the DEACM-caged SIH compound 78 including the intact (CIC) or UVA-
irradiated NPE-caged compound (CIC + UV), along with the ‘naked’ SIH IC 10 is 
shown in Figure 2.30.  As with the other caged-SIH compounds, 78 shows higher 
toxicity than the parental SIH iron chelator; however, unusually the irradiated CIC 
exhibits high anti-proliferative activity which does not correspond to the cytotoxicity of 
SIH.  In light of these data however, it should be borne in mind that the decaging 
profile for this compound (see Figure 2.14) suggested only partial SIH photorelease 
following UVA-irradiation, along with the generation of additional, unidentified 
photoproducts.  The findings shown below suggest that these additional 
photoproducts may be toxic, owing to the increase in cellular growth inhibition which 
is seen in cells treated with the irradiated CIC. 
 
Figure 2.29.  MTT assay for the ‘naked’ (IC, 8), NV-caged (CIC, 67) and UVA-irradiated NV-caged 
(CIC + UVA) derivatives of PIH at 100 M in HaCaT cells (n = 2-3). 






























Figure 2.30.  MTT assay for the ‘naked’ (IC, 10), DEACM-caged (CIC, 78) and UVA-irradiated DEACM-
caged (CIC + UVA) derivatives of SIH at 20 M (A) and  40 M (B) in HaCaT cells (n = 2-3). 
*  p < 0.05, significantly different from control cells at same timepoint.  









2.7.3. Comparative toxicity of CICs and UVA-irradiated CICs by BrdU assay 
The growth inhibitory effect of the aroylhydrazone ICs PIH, SIH and NIH, along with 
their NPE-caged derivatives and UVA-irradiated NPE-caged derivatives was 
evaluated by BrdU assay (Figure 2.31, A).  This was also conducted for the sulfur-
containing ICs NT44mT, NT and H2PTBH along with the corresponding NPE-caged 




















Figure 2.31.  BrdU assay: Growth inhibitory effect of aroylhydrazones PIH 8, SIH 10 and NIH 11 (A) and 
sulfur-containing ICs NT44mT and NT (54a-b respectively), and H2PTBH 56 (B), along with their NPE-
caged (CIC) and UVA-irradiated NPE-caged derivatives 72 h post-treatment. (n = 1) 
 
 
NT44mT (10 M) 
79 
 
The BrdU assay shows the percentage of cells in S phase, and thus gives a measure 
of the proportion of cells continuing to undergo DNA synthesis in preparation for 
mitosis.  For the compounds NIH 11, NT44mT 54a, NT 54b and H2PTBH 56, and 
their caged derivatives, there is a good degree of correspondence between these 
results and the growth inhibitory effects measured by MTT assay.  The 
aroylhydrazones PIH and SIH and their derivatives however display activity which 
differs from that measured with the MTT assay. For example, irradiated NPE-PIH 
does not appear to exert any biological activity, as a higher percentage of cells 
treated with irradiated NPE-PIH progress to S phase compared to the untreated 
controls; furthermore, according to the BrdU data, NPE-SIH displays higher 
cytotoxicity than the parental SIH chelator.   
As shown with the MTT assay, NIH 11 and its NPE-caged derivative 53 shows the 
most favourable biological profile, as cells treated with the caged compound are 
more likely to progress to S phase than those treated with the parent or UVA-
irradiated caged chelator.  Following UVA-irradiation, the cytotoxicity of NPE-NIH 
does not appear to be fully restored to that of NIH, a finding which was also observed 
in the MTT assays.  This same effect is also displayed with the sulfur-based iron 
chelators NT44mT 54a and H2PTBH 56, where there is no significant difference 












2.7.4. Decaging of NPE-NIH “in vivo” 
The comparative toxicity studies of the caged compounds and their derivatives 
discussed in the previous section suggest that NPE-NIH exhibits the most attractive 
biological profile, as its potent cytotoxicity is only observed following UVA irradiation, 
whereas the intact CIC has no significant antiproliferative effect.  
The assays described in section 2.7.3 however use “pre-irradiated” CICs, and cannot 
be used to show that uncaging of the CIC occurs within cells during exposure to 
physiologically relevant doses of UVA radiation.  This is important as the dose of 
UVA that a compound is exposed to within a cell will be decreased compared to its 
irradiation outside a cell, as a significant degree of UVA is absorbed by intracellular 
chromophores.  Therefore, a further experiment was conducted to help demonstrate 
that NPE-NIH 53 is uncaged within HaCaT cells when the cells are irradiated with 
UVA.  Cells were left untreated (control) or incubated for 72 h following treatment 
with NIH or NPE-NIH at 5 M. Cells were then irradiated with UVA at a dose of 50, 
100 or 250 kJ/m2, or alternatively not exposed to UVA (‘dark’).  Figure 2.32 displays 












Figure 2.32.  MTT assay of HaCaT cells in the absence or presence of UVA radiation following 






HaCaT cells are particularly suitable for this type of experiment, as they demonstrate 
a high level of resistance to UVA-induced damage, and it is apparent from Figure 
2.32 that in control cells which were untreated with compound there are no signs of 
cell death up to a UVA dose of 100 kJ/m2.  Cells which were exposed to the ‘naked’ 
NIH iron chelator on the other hand display a marked reduction in cell growth 
compared to the untreated controls, thus suggesting that the observed cytotoxicity in 
cells irradiated at low UVA doses is attributable only to NIH.  As anticipated, cells 
treated with the CIC NPE-NIH exhibit no signs of cell death is not exposed to UVA 
radiation; however at even low doses of UVA radiation (50 and 100 kJ/m2), there is a 
dramatic reduction in the growth rate of cells, suggesting that uncaging is taking 
place to liberate the free NIH iron chelator, which is evidently eliciting a potent 
antiproliferative effect.  This data also suggests however that the irradiated cells 
treated with NPE-NIH are more susceptible to cell death compared to those treated 
with the naked chelator, and the control cells irradiated at 50-100 kJ/m2 appear to 















2.7.5. Toxicity of nitrosophenylketone (NPK) in HaCaT cells 
NPK (35) is one of the two expected photoproducts released following NPE-CIC 
photolysis with UVA; however there are currently no known studies where the 
biological effects of NPK in cellular systems are explicitly evaluated.  Any activity that 
NPK exerts on cells however could have a substantial impact on the biological 
outcome of NPE-CICs, and any results observed from irradiated CICs may not reflect 
the action of the “active” IC fragment.  For this reason, a preliminary assessment of 
the biological effects of NPK in HaCaT cells was undertaken. 
NPK toxicity was evaluated using the MTT assay as previously described.  Cells 
were treated with NPK at 20, 40 or 100 M and any reductions in growth were 
measured at 24, 48 and 72 h.  In addition, some cells were also treated with SIH, and 
the thiosemicarbazone chelator NT as a comparison, as well as mixtures of NPK and 
these ICs which should ‘mimic’ the release of these fragments following photolysis of 
the NPE-CIC.  The rationale for this was to try and elucidate the comparative toxicity 
results for the UVA-irradiated sulfur-containing ICs, where in all cases the irradiated 
CIC did not exhibit the same level of toxicity as the parental chelator.  A possibility for 
this is that the addition of NPK attenuates the activity of the chelator, which could 
occur through an interaction of the thioamide sulfur and the nitroso function of NPK. 
The reaction of thiols and nitroso compounds has already been reported by Corrie et 









Scheme 2.22.  Mechanism of NPK reaction with thiolate ion RS to give benzisoxazole 85, as proposed 










The results obtained show that NPK elicits relatively low toxicity, as it does not 
appear to have any significant effect on cell growth at concentrations up to 40 M 
(Figure 2.33); however significant toxicity is observed at high concentrations (100 
M). For lipophilic NPE-caged iron chelators, such as SIH and NIH, these results are 
unlikely to have a significant impact, as the antiproliferative activity of these ICs is 
apparent at concentrations significantly below those for NPK; however for 
compounds with less potent antiproliferative effects, such as PIH which has an IC50 
value of 100 M in HaCaT cells, any toxic effects observed could be a consequence 
of NPK and not the IC.  Interestingly, this theory is not evident from comparative MTT 
assay results of PIH and its NPE-caged derivative (Figure 2.24), as the toxicity 












Comparison of the growth inhibitory effect of cells treated with NPK and SIH or a 
mixture of NPK/SIH are shown in Figure 2.34, where at a concentration of 20 M 
cells treated with a mixture of NPK and SIH show no significant growth retardation 
compared to those treated with SIH alone.  This is consistent with the results shown 
in Figure 2.33 that NPK elicits no significant toxicity at 20 M. 
Figure 2.33.  MTT assay: toxicity of NPK 35 in HaCaT cells after incubation for 24, 48 or 72 h (n = 3).  



















Comparison of the growth inhibitory effect of cells treated with NPK and NT, or a 
mixture of NPK/NT are shown in Figure 2.35, where it is apparent that a mixture of 
NPK/NT does not have any significant growth inhibitory effects compared to NT or 
NPK alone.  Furthermore, the degree of toxicity observed in cells after a 72 h 
treatment time with the NPK/NT mixture appears to correspond to that observed in 
cells with irradiated NPE-NT at the same timepoint.  It fails however to suggest that 
NPK is attenuating the effects of the sulfur-containing  NT chelator, as toxicity is 









Figure 2.34. MTT assay for NPK 35, SIH 10, or a mixture of 35/10 at 20 M in HaCaT cells (n = 3).   
 p < 0.05, significantly different from corresponding untreated controls. 
Figure 2.35. MTT assay for NPK 35, NT 54b, or a mixture of 35/54b at 10 M in HaCaT cells (n = 3).   
 p < 0.05, significantly different from corresponding untreated controls. 




It would therefore appear that there is no interaction between NPK and the NT iron 
chelator.  To confirm this theory, a mixture of NPK and NT were dissolved together in 
DMSO at a concentration of 0.5 mg/mL, and analysed by HPLC at 4 and 24 h.  The 
chromatogram did not suggest the formation of any new products (not shown). 
 
 
2.8. Future work 
The MTT, BrdU and CFA assay results presented in this chapter have helped to 
elucidate the biological profiles of the CICs described herein, although for many of 
these compounds the results obtained represent only a preliminary stage of the 
investigatory work required.   
The biological data obtained suggest that the NPE-caged sulfur-based ICs do not 
exert the expected in vitro effects following irradiation with UVA.  It has also been 
observed that aroylhydrazones caged with the NV or DEACM moieties are toxic to 
the cell lines used, thus suggesting that NPE-CICs possess a more favourable 
toxicity profile.  Further biological assays are required to validate these results, and to 
identify whether the same effects are observed in an alternative cell line, such as 
FEK4 fibroblasts for example, or another tumourigenic skin cell line. 
Furthermore, decaging profiles of the NPE-CICs appear to show more attractive 
photolytic behaviour than their NV or DEACM counterparts, and these findings, 
combined with the synthetic work described has allowed for a proof-of-concept study 
into the caging of aroylhydrazone ICs and their derivatives with various caging 
groups.  Further studies on the wavelength specific cleavage of DEACM-CICs 75 and 
78 are therefore required by utilising a different light source. 
 
 
 
 
